Actively Recruiting

Age: 40Years - 85Years
All Genders
Healthy Volunteers
ID04865172

ECOCAPTURE@HOME: Program for the Assessment of Behavioural Markers of Apathy Under Real-life Conditions Aimed At Patients with Neurodegenerative Dementias and Their Caregivers

Led by Institut National de la Santé Et de la Recherche Médicale, France · Updated on 2024-11-21

120

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to identify and measure behavioral signs of apathy in daily life among patients with neurodegenerative dementias and their caregivers. The study involves groups of patient-caregiver pairs affected by behavioral variant Frontotemporal Dementia (bvFTD), Alzheimer Disease (AD), and healthy control couples. The goal is to develop a remote monitoring tool to better understand and track apathy, which greatly affects quality of life but is difficult to define and measure objectively. Participants will wear a multi-sensor bracelet continuously for 28 days to collect passive data like physical activity, electrodermal activity, and blood volume pulse. Caregivers will also complete weekly questionnaires via a smartphone app about behaviors related to meals, sleep, and daily activities. The study compares data from three groups: bvFTD patient-caregiver dyads, AD patient-caregiver dyads, and healthy control dyads. During the 28-day period, researchers will gather continuous sensor data and weekly questionnaire responses to evaluate three key behavioral markers of apathy: daytime activity, sleep quality, and emotional arousal. They will analyze these markers on daily and monthly scales and assess how well they predict caregivers' perceptions of psychological states. This monitoring may help improve future care and support for patients and their caregivers.

CONDITIONS

Brief Title

ECOCAPTURE for the Assessment of Apathy Under Real-life Conditions

Who Can Participate

Age: 40Years - 85Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients diagnosed with behavioral variant Frontotemporal Dementia (bvFTD) or Alzheimer Disease (AD) according to international criteria
  • Aged between 40 and 85 years old
  • Mini-Mental State Evaluation (MMSE) score of 10 or higher
  • No evidence of other brain diseases
  • No psychiatric conditions and a Montgomery-Åsberg Depression Rating Scale (MADRS) score below 20
  • No excessive use of psychotropic drugs such as benzodiazepines or sleeping pills
  • No major physical disability affecting mobility
  • No heart pacemaker
  • Caregivers and healthy control partners aged between 40 and 85 years old
  • Caregivers with no psychiatric conditions and MADRS score below 20
  • Caregivers with no excessive use of psychotropic drugs
  • Caregivers with no major physical disability affecting mobility
  • Caregivers with no heart pacemaker
Not Eligible

You will not qualify if you...

  • Persons detained by judicial or administrative decision
  • Persons under legal protection orders
  • Persons excluded due to participation in another research study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - 28 consecutive days

Participants wear a multi-sensor wearable bracelet to collect passive behavioral data continuously. Active behavioral data is collected through weekly questionnaires completed by caregivers in patient-caregiver dyads using a smartphone application.

Weekly visits for questionnaires during the 4 weeks

Trial Site Locations

Total: 1 location

1

ICM, Hôpital Salpêtrière

Paris, France, 75013

Actively Recruiting

Loading map...

Research Team

R

Richard Levy, MD, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Similar Trials

Comparison of Cardiac [18F]-MFBG PET Versus [123I]-MIBG SPEC...

Parkinson Disease

Actively Recruiting

2 locations

An Open-label, Non-randomized, Multi-center Pivotal Phase 3 ...

Alzheimer Disease

Actively Recruiting

25 locations

A Feasibility Study of Green Activity Program for People Liv...

Mild Cognitive Impairment

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial